CaRISMA Study: An alternative way to manage sickle cell disease

verified Patient-friendly certified What is this?
The Sickle Cell 101 research team in collaboration with study investigator have reviewed this information to ensure it is patient-friendly and accurate.

About the Study

To identify treatments that do not rely only on opioids or other medications. Participants will use their smartphone to answer questionnaires and interact with a mobile application.

Participation information

Countries

1 United States site

Age

18 years or older

Gender

All

Genotypes

All types of SCD

Study Information

Study type

Digital

Interventions

c-CBT, m-Education

Phase

N/A

Compensation

No

Am I Eligible?

Requirements

You may be eligible to participate in this study if you:
  • People with any type of sickle cell disease
  • Male or female,
  • Age 18 years or older
  • Reports chronic pain: i.e pain more days than not for the past 3 months or longer and/or is prescribed daily or long-acting opioids for pain.
  • English speaking

Restrictions

You can't participate in this study if you:
  • Any potential participants who fail consent comprehension questions

Study point of contact

Charles Jonassaint, PhD, MHS
412-586-9850
[email protected]

Study Sites

  • United States
ClinicalTrials.gov Enroll in this Study
Last updated October 4, 2022